- Home
- BODI vs ESLA Comparison
BODI vs ESLA Comparison
Compare BODI & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BODI | ESLA |
|---|---|---|
| Founded | 1998 | 2021 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.2M | 60.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BODI | ESLA |
|---|---|---|
| Price | $8.70 | $1.22 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $8.00 | $8.00 |
| AVG Volume (30 Days) | 35.4K | ★ 384.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.38 | $0.73 |
| 52 Week High | $12.66 | $3.15 |
Technical Indicators
Market Signals| Indicator | BODI | ESLA |
|---|---|---|
| Relative Strength Index (RSI) | 37.58 | 49.43 |
| Support Level | $8.28 | $1.14 |
| Resistance Level | $12.66 | $1.33 |
| Average True Range (ATR) | 0.78 | 0.19 |
| MACD | -0.30 | 0.03 |
| Stochastic Oscillator | 11.87 | 49.09 |
Price Performance
Historical ComparisonAbout BODI The Beachbody Company Inc.
The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.